Welcome to Exiqon's Investor Site Exiqon maintains an open and continuous dialogue with existing and potential shareholders, stakeholders and the general public. We aim for a high degree of openness and we are committed to communicating information in compliance with the disclosure requirements of the NASDAQ OMX Copenhagen A/S. Exiqon publishes quarterly reports on the company's development, including relevant financial information. In addition, we will publish details about the company where such information is considered important to the pricing of its shares. Exiqon maintains an insider register and will publish any changes to certain insiders' shareholdings in accordance with the rules that apply for NASDAQ OMX Copenhagen A/S. Any such publication will be made immediately after the transaction. We have adopted in-house rules that only allow insiders to purchase and sell shares in Exiqon A/S during a 28 day period after the company's publication of interim financial statements. Such information will first be published via the websites of the NASDAQ OMX in Copenhagen (www.omxnordicexchange.com) and will immediately thereafter be available here on our website. Shareholders and others who via our website have requested the receipt of e-mail news from the Exiqon, will receive the information immediately thereafter. We respect the principle of equal treatment of all market players to ensure fair pricing of the Exiqon's shares. Latest share info     Supplied by NASDAQ OMX   Recent Annual Reports   2009   2009 - UK    2009 - DK  See more reports Articles of Association Show latest Articles of Association Analyses of Exiqon stock Se analyse fra AktieInfo.net her Upcoming Events 9 September 2010, CET 17:00-20:15, Copenhagen Meet Exiqon at the biotech investor event hosted by ProInvestor, IT-Universitetet, Rued Langgaards Vej 7, 2300 Copenhagen S 6 October 2010, Vedbaek, Denmark Nordea Markets, Healthcare tour for institutional investors Exiqon Announcements 19 August 2010 Exiqon A/S - Interim report for the period 1 January - 30 June 2010 (unaudited) 20 July 2010 Exiqon A/S - Roche and Exiqon Agree on Joined Marketing Approach for their RT PCR Assay Systems 29 June 2010 Exiqon A/S - Exiqon's Articles of Association as of 29 June 2010 More announcements   Investor Brochures   Exiqon at a glance - UK PDF 36 KB Exiqon at a glance - DK PDF 36 KB Investor Signup Signup to receive investor news Please register your email in Exiqon’s Investor Portal to receive notices convening annual and extraordinary general meetings by email Register your email by logging on to the Investor Portal here Exiqon Presentations Download Exiqon's latest investor presentations Exiqon Webcasts Exiqon's NIM Presentation 2009, May 20, 2009 Webcast presentation of the Exiqon Annual Report 2008, March 3, 2009